Shanghai INT Medical Valuation Multiples

Shanghai INT Medical is valued at $795M as of November 2026, a 4.7x revenue multiple. In the last 12 months, Shanghai INT Medical revenue was $154M.

Shanghai INT Medical Overview

About Shanghai INT Medical

Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention, or implantation, and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, the United States, and Other countries and regions. The majority of the revenue comes from the Chinese Mainland.


Founded

2006

HQ

China

Employees

1.7K

Financials (LTM)

Revenue: $154M
Net Income: $34M

EV

$722M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Shanghai INT Medical Financials

Shanghai INT Medical reported last 12-month revenue of $154M.

In the same LTM period, Shanghai INT Medical generated $34M in net income.

Revenue (LTM)


Shanghai INT Medical P&L

In the most recent fiscal year, Shanghai INT Medical reported revenue of $160M and EBITDA of $54M.

Shanghai INT Medical is profitable as of last fiscal year, with gross margin of 60%, EBITDA margin of 34%, and net margin of 21%.

See analyst estimates for Shanghai INT Medical
LTMLast FY2025202620272028
Revenue$154M$160M$160M
Gross Profit-$96M$96M
Gross Margin-60%60%
EBITDA-$54M$54M
EBITDA Margin-34%34%
EBIT Margin-24%24%
Net Profit$34M$33M$33M
Net Margin22%21%21%
Net Debt-$13M-

Financial data powered by Morningstar, Inc.

Shanghai INT Medical Stock Performance

Shanghai INT Medical has current market cap of $795M, and enterprise value of $722M.

Market Cap Evolution


Shanghai INT Medical's stock price is $3.80.

Shanghai INT Medical share price decreased by 0.7% in the last 30 days.

Shanghai INT Medical has an EPS (earnings per share) of $0.16.

See more trading valuation data for Shanghai INT Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$722M$795M0.9%-0.7%--$0.16

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Shanghai INT Medical Valuation Multiples

Shanghai INT Medical trades at 4.7x EV/Revenue multiple, and 13.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Shanghai INT Medical

EV / Revenue (LTM)


Shanghai INT Medical Financial Valuation Multiples

As of November 6, 2026, Shanghai INT Medical has market cap of $795M and EV of $722M.

Shanghai INT Medical has a P/E ratio of 23.6x.

LTMLast FY2025202620272028
EV/Revenue4.7x4.5x4.5x
EV/EBITDA-13.2x13.2x
EV/EBIT-18.6x18.6x
EV/Gross Profit-7.6x7.6x
P/E23.6x24.2x24.2x
EV/FCF-21.8x21.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Shanghai INT Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Shanghai INT Medical Margins & Growth Rates

In the most recent fiscal year, Shanghai INT Medical reported gross margin of 60%, EBITDA margin of 34%, and net margin of 21%.

See estimated margins and future growth rates for Shanghai INT Medical

Shanghai INT Medical Margins

Last FY2025202720282029
Gross Margin60%60%
EBITDA Margin34%34%
EBIT Margin24%24%
Net Margin21%21%
FCF Margin21%21%

Data powered by FactSet, Inc. and Morningstar, Inc.

Shanghai INT Medical Operational KPIs

Shanghai INT Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Shanghai INT Medical
Last FY2025202620272028
Revenue per Employee$0.1M-
Opex per Employee$0.0M-
S&M Expenses to Revenue11%11%
G&A Expenses to Revenue14%14%
R&D Expenses to Revenue14%14%
Opex to Revenue35%35%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Shanghai INT Medical Competitors

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E

This data is available for Pro users. Sign up to see all Shanghai INT Medical competitors and their valuation data.

Start Free Trial

Acquisitions by Shanghai INT Medical

Shanghai INT Medical has acquired 1 company to date.

Last acquisition by Shanghai INT Medical was on September 11th 2026. Shanghai INT Medical acquired Valgen Medtech for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Shanghai INT Medical

Valgen Medtech
Description
Valgen Medtech is a Shanghai-headquartered medical device company specializing in transcatheter solutions for mitral and tricuspid valve diseases. Products include the Valgen Mitral Valve Repair System and Tricuspid Annuloplasty Device, designed for percutaneous delivery to restore valve function in high-risk patients. The firm conducts trials in China and pursues FDA approvals for U.S. market entry.
HQ CountryChina
HQ City
Hangzhou
Deal Date11 Sep 2026
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Shanghai INT Medical acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Shanghai INT Medical

When was Shanghai INT Medical founded?Shanghai INT Medical was founded in 2006.
Where is Shanghai INT Medical headquartered?Shanghai INT Medical is headquartered in China.
How many employees does Shanghai INT Medical have?As of today, Shanghai INT Medical has over 1K employees.
Is Shanghai INT Medical publicly listed?Yes, Shanghai INT Medical is a public company listed on HKEX.
What is the stock symbol of Shanghai INT Medical?Shanghai INT Medical trades under 01501 ticker.
When did Shanghai INT Medical go public?Shanghai INT Medical went public in 2019.
Who are competitors of Shanghai INT Medical?Shanghai INT Medical main competitors include
What is the current market cap of Shanghai INT Medical?Shanghai INT Medical's current market cap is $795M.
What is the current revenue of Shanghai INT Medical?Shanghai INT Medical's last 12 months revenue is $154M.
What is the current EV/Revenue multiple of Shanghai INT Medical?Current revenue multiple of Shanghai INT Medical is 4.7x.
What is the current net income of Shanghai INT Medical?Shanghai INT Medical's last 12 months net income is $34M.
How many companies Shanghai INT Medical has acquired to date?As of November 2026, Shanghai INT Medical has acquired 1 company.
What was the largest acquisition by Shanghai INT Medical?None of the M&A deals Shanghai INT Medical has completed have disclosed valuations.
What companies Shanghai INT Medical acquired?Shanghai INT Medical acquired Valgen Medtech.
In how many companies Shanghai INT Medical has invested to date?Shanghai INT Medical hasn't invested in any companies yet (or none have been disclosed publicly).

Lists including Shanghai INT Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial